These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28643790)
1. Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Bengtsson NE; Hall JK; Odom GL; Phelps MP; Andrus CR; Hawkins RD; Hauschka SD; Chamberlain JR; Chamberlain JS Nat Commun; 2017 Jun; 8():16007. PubMed ID: 28643790 [TBL] [Abstract][Full Text] [Related]
2. The AAV-mediated and RNA-guided CRISPR/Cas9 system for gene therapy of DMD and BMD. Wang JZ; Wu P; Shi ZM; Xu YL; Liu ZJ Brain Dev; 2017 Aug; 39(7):547-556. PubMed ID: 28390761 [TBL] [Abstract][Full Text] [Related]
4. Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy. Amoasii L; Long C; Li H; Mireault AA; Shelton JM; Sanchez-Ortiz E; McAnally JR; Bhattacharyya S; Schmidt F; Grimm D; Hauschka SD; Bassel-Duby R; Olson EN Sci Transl Med; 2017 Nov; 9(418):. PubMed ID: 29187645 [TBL] [Abstract][Full Text] [Related]
5. Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9. Chen Y; Zheng Y; Kang Y; Yang W; Niu Y; Guo X; Tu Z; Si C; Wang H; Xing R; Pu X; Yang SH; Li S; Ji W; Li XJ Hum Mol Genet; 2015 Jul; 24(13):3764-74. PubMed ID: 25859012 [TBL] [Abstract][Full Text] [Related]
6. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells. Young CS; Hicks MR; Ermolova NV; Nakano H; Jan M; Younesi S; Karumbayaram S; Kumagai-Cresse C; Wang D; Zack JA; Kohn DB; Nakano A; Nelson SF; Miceli MC; Spencer MJ; Pyle AD Cell Stem Cell; 2016 Apr; 18(4):533-40. PubMed ID: 26877224 [TBL] [Abstract][Full Text] [Related]
7. A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping. Shimo T; Hosoki K; Nakatsuji Y; Yokota T; Obika S J Hum Genet; 2018 Mar; 63(3):365-375. PubMed ID: 29339778 [TBL] [Abstract][Full Text] [Related]
8. Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells. Maggio I; Liu J; Janssen JM; Chen X; Gonçalves MA Sci Rep; 2016 Nov; 6():37051. PubMed ID: 27845387 [TBL] [Abstract][Full Text] [Related]
9. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy. Nik-Ahd F; Bertoni C Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122 [TBL] [Abstract][Full Text] [Related]
10. Duchenne muscular dystrophy: an updated review of common available therapies. Salmaninejad A; Valilou SF; Bayat H; Ebadi N; Daraei A; Yousefi M; Nesaei A; Mojarrad M Int J Neurosci; 2018 Sep; 128(9):854-864. PubMed ID: 29351004 [TBL] [Abstract][Full Text] [Related]
11. Scalpel or Straitjacket: CRISPR/Cas9 Approaches for Muscular Dystrophies. Himeda CL; Jones TI; Jones PL Trends Pharmacol Sci; 2016 Apr; 37(4):249-251. PubMed ID: 26917062 [TBL] [Abstract][Full Text] [Related]
12. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy. Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404 [TBL] [Abstract][Full Text] [Related]
13. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy. Ito M; Ehara Y; Li J; Inada K; Ohno K Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975 [TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Deconinck N; Dan B Pediatr Neurol; 2007 Jan; 36(1):1-7. PubMed ID: 17162189 [TBL] [Abstract][Full Text] [Related]
15. The emerging role of viral vectors as vehicles for DMD gene editing. Maggio I; Chen X; Gonçalves MA Genome Med; 2016 May; 8(1):59. PubMed ID: 27215286 [TBL] [Abstract][Full Text] [Related]
16. Decreased cerebral perfusion in Duchenne muscular dystrophy patients. Doorenweerd N; Dumas EM; Ghariq E; Schmid S; Straathof CS; Roest AA; Wokke BH; van Zwet EW; Webb AG; Hendriksen JG; van Buchem MA; Verschuuren JJ; Asllani I; Niks EH; van Osch MJ; Kan HE Neuromuscul Disord; 2017 Jan; 27(1):29-37. PubMed ID: 27927595 [TBL] [Abstract][Full Text] [Related]
17. Genomic integration of the full-length dystrophin coding sequence in Duchenne muscular dystrophy induced pluripotent stem cells. Farruggio AP; Bhakta MS; du Bois H; Ma J; P Calos M Biotechnol J; 2017 Apr; 12(4):. PubMed ID: 28139886 [TBL] [Abstract][Full Text] [Related]